Curacyte AG: PHOENIX Phase III Trial of PHP for Distributive Shock to Continue after Positive Midpoint Recommendation from DMB
3/28/2011 11:14:53 AM
More...
|
Curacyte AG Sells Its Subsidiary Curacyte Discovery GmbH to The Medicines Company (MDCO) for €14.5 Million
8/5/2008 4:34:38 PM
More...
|
Curacyte AG Appoints Dr. David Ebsworth To Chairman Of Its Supervisory Board
10/19/2005 5:13:13 PM
More...
|
Curacyte AG And IBFB PHARMA GmbH Announce Merger; Series C Financing Round Of €16.5 Million ($21.6 Million) Closed On Back Of The Merger
10/19/2005 5:12:49 PM
More...
|
Curacyte AG Announces Successful Completion Of Phase II Study For PHP In Distributive Shock, Its Lead Product
10/19/2005 5:09:45 PM
More...
|